|
|
Volumn 10, Issue 10, 2011, Pages 727-728
|
|
Antibacterial R&D incentives
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
ANTIMALARIAL AGENT;
ORPHAN DRUG;
PNEUMOCOCCUS VACCINE;
VACCINE;
ADVERSE OUTCOME;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
ARTICLE;
COMBINATION CHEMOTHERAPY;
COST EFFECTIVENESS ANALYSIS;
CROSS RESISTANCE;
DIAGNOSTIC TEST;
DISEASE SURVEILLANCE;
DRUG APPROVAL;
DRUG COMPETITION;
DRUG COST;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG INTERACTION;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG MECHANISM;
DRUG MISUSE;
DRUG RESEARCH;
DRUG SENSITIVITY;
DRUG STABILITY;
DRUG TREATMENT FAILURE;
DRUG USE;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
FUNDING;
GOVERNMENT REGULATION;
HEALTH CARE NEED;
HEALTH PROGRAM;
HUMAN;
LEGAL LIABILITY;
LIFE EXTENSION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MULTIDRUG RESISTANCE;
NEGLECTED DISEASE;
OUTCOME ASSESSMENT;
PATENT;
PATIENT COMPLIANCE;
POLICY;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
PUBLIC-PRIVATE PARTNERSHIP;
REIMBURSEMENT;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
STREPTOCOCCUS PNEUMONIA;
TAX;
TREATMENT DURATION;
TREATMENT INDICATION;
TREATMENT RESPONSE;
TROPICAL DISEASE;
ANIMALS;
ANTI-BACTERIAL AGENTS;
DRUG DISCOVERY;
DRUG INDUSTRY;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
RESEARCH;
|
|
EID: 80053533775
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3560 Document Type: Article |
|
Times cited : (19)
|
|
References (5)
|
